Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark B. Mitchell is active.

Publication


Featured researches published by Mark B. Mitchell.


Journal of Organic Chemistry | 2011

An enyne cycloisomerization approach to the triple reuptake inhibitor GSK1360707F.

Nicole M. Deschamps; Vassil I. Elitzin; Bing Liu; Mark B. Mitchell; Matthew J. Sharp; Elie A. Tabet

The triple reuptake inhibitor GSK1360707F was synthesized via an efficient and scalable route that features an enyne cycloisomerization reaction catalyzed by either Pt(II) or Au(I). Key aspects of this work such as the choice of the nitrogen protecting group and initial enantioselectivity studies are discussed.


Journal of Organic Chemistry | 2013

Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehyde.

Roy K. Bowman; Andrew D. Brown; Jannine H. Cobb; John F. Eaddy; Mark Andrew Hatcher; Martin Robert Leivers; John F. Miller; Mark B. Mitchell; Daniel E. Patterson; Matthew A. Toczko; Shiping Xie

A robust convergent synthesis of the prodrugs of HCV replicase inhibitors 1-5 is described. The central 5H-imidazo[4,5-d]pyridazine core was formed from acid-catalyzed cyclocondensation of an imidazole-4,5-dicarbaldehyde (20) and a α-hydrazino ester, generated in situ from the bis-BOC-protected precursors 25 and 33. The acidic conditions not only released the otherwise unstable α-hydrazino esters but also were the key to avoid facile decarboxylation to the parent drugs from the carboxylic ester prodrugs 1-5. The bis-BOC α-hydrazino esters 25 and 33 were prepared by addition of ester enolates (from 23 and 32) to di-tert-butyl azodicarboxylate via catalysis with mild inorganic bases, such as Li2CO3. A selective aerobic oxidation with catalytic 5% Pt-Bi/C in aqueous KOH was developed to provide the dicarbaldehyde 20 from the diol 27.


Journal of Organic Chemistry | 2013

Enzymatic- and Iridium-Catalyzed Asymmetric Synthesis of a Benzothiazepinylphosphonate Bile Acid Transporter Inhibitor

David John Cowan; Jon L. Collins; Mark B. Mitchell; John A. Ray; Peter W. Sutton; Amy A. Sarjeant; Eric E. Boros

A synthesis of the benzothiazepine phosphonic acid 3, employing both enzymatic and transition metal catalysis, is described. The quaternary chiral center of 3 was obtained by resolution of ethyl (2-ethyl)norleucinate (4) with porcine liver esterase (PLE) immobilized on Sepabeads. The resulting (R)-amino acid (5) was converted in two steps to aminosulfate 7, which was used for construction of the benzothiazepine ring. Benzophenone 15, prepared in four steps from trimethylhydroquinone 11, enabled sequential incorporation of phosphorus (Arbuzov chemistry) and sulfur (Pd(0)-catalyzed thiol coupling) leading to mercaptan intermediate 18. S-Alkylation of 18 with aminosulfate 7 followed by cyclodehydration afforded dihydrobenzothiazepine 20. Iridium-catalyzed asymmetric hydrogenation of 20 with the complex of [Ir(COD)2BArF] (26) and Taniaphos ligand P afforded the (3R,5R)-tetrahydrobenzothiazepine 30 following flash chromatography. Oxidation of 30 to sulfone 31 and phosphonate hydrolysis completed the synthesis of 3 in 12 steps and 13% overall yield.


Journal of Organic Chemistry | 2003

Concise synthesis, preparative resolution, absolute configuration determination, and applications of an atropisomeric biaryl catalyst for asymmetric acylation.

Alan C. Spivey; Fujiang Zhu; Mark B. Mitchell; Stephen G. Davey; Richard L. Jarvest


Organic Process Research & Development | 2010

Expedited Development through Parallel Reaction Screening: Application to PTC-Mediated Knoevenagel Condensation

John Corona; Roman Davis; Sandeep B. Kedia; Mark B. Mitchell


Organic Process Research & Development | 2009

Reaction Progress Analysis: Powerful Tool for Understanding Suzuki−Miyaura Reaction and Control of Polychlorobiphenyl Impurity

Sandeep B. Kedia; Mark B. Mitchell


Organic Process Research & Development | 2009

Process Development and Scale-Up of a PPARγ Agonist: Selection of the Manufacture Route

Kae M. Bullock; Delphilia Burton; John Corona; Ann Marie Diederich; Bobby N. Glover; Kim Harvey; Mark B. Mitchell; Mark D. Trone; Robert Yule; Yong Zhang; Jennifer F. Toczko


European Journal of Organic Chemistry | 2012

Highly Selective Primary Alkoxycarboxylation and Esterification of Unprotected Pyranose Derivatives Mediated by Scandium(III) Triflate Catalysis

Michael S. McClure; Malcolm B. Berry; Darren Caine; Claire Crawford; Brian C. Crump; Bobby N. Glover; Sandeep B. Kedia; Alan Millar; Mark B. Mitchell; Christopher J. Nichols; Daniel E. Patterson; Jeremiah D. Powers


Organic Process Research & Development | 2016

Development of Large-Scale Routes to Potent GPR119 Receptor Agonists

Richard T. Matsuoka; Eric E. Boros; Andrew D. Brown; Kae M. Bullock; Will L. Canoy; Andrew J. Carpenter; Jeremy D. Cobb; Shannon E. Condon; Nicole M. Deschamps; Vassil I. Elitzin; Greg Erickson; Jing M. Fang; David H. Igo; Biren K. Joshi; Istvan Kaldor; Mark B. Mitchell; Gregory Peckham; Daniel W. Reynolds; Matthew C. Salmon; Matthew J. Sharp; Elie A. Tabet; Jennifer F. Toczko; Lianming Michael Wu; Xiao-ming M. Zhou


Tetrahedron Letters | 2014

Synthesis of Lapatinib via direct regioselective arylation of furfural

Greg Erickson; Jiasheng Guo; Mike McClure; Mark B. Mitchell; Marie-Catherine Salaun; Andrew Jonathan Whitehead

Collaboration


Dive into the Mark B. Mitchell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elie A. Tabet

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge